Abstract | OBJECTIVE: To investigate the clinical features of distant metastatic penile cancer ( DMPC) and the factors influencing its prognosis. METHODS: We searched the Surveillance, Epidemiology and End Results Database for cases of DMPC diagnosed between 2004 and 2019, analyzed their clinical characteristics and the cancer-specific survival (CSS) rates relating to different factors using the Kaplan-Meier method and the differences among the variables by log-rank test. We determined the variables independently associated with CSS by Cox regression analysis. RESULTS: According to the inclusion criteria, 108 cases of DMPC were identified. The patients were mainly married White people, with a median CSS of 9 months, and 1-, 2- and 3-year CSS rates of 36.4%, 17.8% and 13.5%, respectively. Pairwise comparison showed no statistically significant differences in the median overall CSS among the patients in the surgery, chemotherapy and surgery + chemotherapy groups (8 mo vs 9 mo vs 13 mo, P > 0.05). Race was an independent factor affecting the prognosis of CSS. CONCLUSION: Distant metastatic penile cancer is a rare malignancy with poor prognosis, for which there have been no existing ideal treatment options.
|
Authors | Chao-Peng Tang, Kai Zhou, Zheng-Cheng Sheng, Yu-Lin Zhou, Shui-Gen Zhou, Song Xu |
Journal | Zhonghua nan ke xue = National journal of andrology
(Zhonghua Nan Ke Xue)
Vol. 29
Issue 2
Pg. 151-157
(Feb 2023)
ISSN: 1009-3591 [Print] China |
PMID | 37847087
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Dimyristoylphosphatidylcholine
|
Topics |
- Male
- Humans
- Prognosis
- Neoplasm Staging
- Penile Neoplasms
(therapy)
- Dimyristoylphosphatidylcholine
|